Patient Handout on SGLT2i

Download Patient SGLT2i Handout
These one-page guide will answer your patient's most common questions when starting an SGLT2i like Jardiance, Farxiga, Invokana, or Steglatro.
Developed by MCT2D Co-Director and clinical pharmacist Heidi Diez, PharmD and MKIC Directors Michael Heung, MD, Julie Wright, MD, MPH, and Rajiv Saran, MD, MBBS, MS, with Lauren Oshman, MD, MPH.
Note: This handout should not be used as a substitute for medical advice from your health care team. It is your responsibility to review information provided by your pharmacy and consult with your doctor or health care team member prescribing these medications with any questions about your medication.
Last revised 3-17-2023.
Patients: Please leave feedback about this tool (counts towards PO-Level VBR requirement)

Tags:

For PatientsCreated-By-MCT2DPDFPoint-of-care

Subscribe to the MCT2D Newsletter

* indicates required
Blue Cross Blue Shield Blue Care Network of Michigan

Support for the Michigan Collaborative on Type 2 Diabetes is provided by Blue Cross Blue Shield of Michigan and Blue Care Network as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs. To learn more about Value Partnerships, visit www.valuepartnerships.com. Although Blue Cross Blue Shield of Michigan and the Michigan Collaborative on Type 2 Diabetes work in partnership, the opinions, beliefs, and viewpoints expressed by MCT2D do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.